Bitcoin pioneer Charlie Shrem peels back the layers on the lives and backgrounds of the world's most impactful innovators. Centering around intimate narratives, Shrem uncovers a detailed, previously unspoken story of the genesis and evolution of bitcoin, cryptocurrency, artificial intelligence, and the web3 movements. Join Shrem as he journeys through the uncharted territories of tech revolutions, revealing the human side of the stories that shaped the digital world we live in today.
…
continue reading
Kandungan disediakan oleh Proactive Investors. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Proactive Investors atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
Bellevue Trust’s Paul Major: small cap healthcare's big opportunity
MP3•Laman utama episod
Manage episode 435404095 series 2891889
Kandungan disediakan oleh Proactive Investors. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Proactive Investors atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major tells Proactive's Stephen Gunnion about the potential benefits for the healthcare sector as tech stocks lose their lustre. Major discussed how the long-overdue rotation from tech could positively impact healthcare, particularly small and mid-cap growth stocks, which stand to gain from a potential decline in interest rates. He pointed out that while tech stocks have seen massive growth, healthcare, especially the biotech sector, might now be poised for significant gains. Major also highlighted the return of the healthcare industry to pre-pandemic norms and the increasing interest in defensive, longer-term earnings within the sector. "Small mid-cap healthcare should be the biggest beneficiary within the wider healthcare investment universe of a negative rate environment," Major said. He further discussed the market's focus on GLP-1 drugs and the potential for new players to emerge as the market broadens. Additionally, Major shared insights on the trust's current cash position and plans for reallocating capital in the coming months. He emphasised the trust's strategy of looking beyond giants like Novo Nordisk and Eli Lilly to identify the next generation of obesity treatments. For more insights from Bellevue Healthcare Trust and other market experts, don't forget to give this video a like, subscribe to the Proactive channel, and enable notifications for future content. #HealthcareStocks #TechStockRotation #PaulMajor #BellevueHealthcare #SmallCapStocks #InterestRates #GLP1Drugs #BiotechInvesting #ProactiveInvestors #InvestmentStrategy #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
608 episod
MP3•Laman utama episod
Manage episode 435404095 series 2891889
Kandungan disediakan oleh Proactive Investors. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Proactive Investors atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Bellevue Healthcare Trust PLC (LSE:BBH) co-portfolio manager Paul Major tells Proactive's Stephen Gunnion about the potential benefits for the healthcare sector as tech stocks lose their lustre. Major discussed how the long-overdue rotation from tech could positively impact healthcare, particularly small and mid-cap growth stocks, which stand to gain from a potential decline in interest rates. He pointed out that while tech stocks have seen massive growth, healthcare, especially the biotech sector, might now be poised for significant gains. Major also highlighted the return of the healthcare industry to pre-pandemic norms and the increasing interest in defensive, longer-term earnings within the sector. "Small mid-cap healthcare should be the biggest beneficiary within the wider healthcare investment universe of a negative rate environment," Major said. He further discussed the market's focus on GLP-1 drugs and the potential for new players to emerge as the market broadens. Additionally, Major shared insights on the trust's current cash position and plans for reallocating capital in the coming months. He emphasised the trust's strategy of looking beyond giants like Novo Nordisk and Eli Lilly to identify the next generation of obesity treatments. For more insights from Bellevue Healthcare Trust and other market experts, don't forget to give this video a like, subscribe to the Proactive channel, and enable notifications for future content. #HealthcareStocks #TechStockRotation #PaulMajor #BellevueHealthcare #SmallCapStocks #InterestRates #GLP1Drugs #BiotechInvesting #ProactiveInvestors #InvestmentStrategy #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
…
continue reading
608 episod
Tüm bölümler
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.